P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support

2002 ◽  
Vol 100 (3) ◽  
pp. 290-296 ◽  
Author(s):  
Manfred Hensel ◽  
Andreas Schneeweiss ◽  
Hans-Peter Sinn ◽  
Gerlinde Egerer ◽  
Erich Solomayer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
High Risk ◽  
Cancer Patients ◽  
Autologous Blood ◽  
High Dose Chemotherapy ◽  
High Dose ◽  
Breast Cancer Patients ◽  
Stem Cell Support ◽  
Cell Support

scholarly journals Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry

2014 ◽  
Vol 20 (4) ◽  
pp. 501-506 ◽  
Author(s):  
Paolo Pedrazzoli ◽  
Giovanni Martinelli ◽  
Alessandro Massimo Gianni ◽  
Gian Antonio Da Prada ◽  
Alberto Ballestrero ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Stem Cell ◽  
High Risk ◽  
Primary Breast Cancer ◽  
High Dose Chemotherapy ◽  
National Registry ◽  
High Dose ◽  
Hematopoietic Stem ◽  
Stem Cell Support ◽  
Cell Support
Sign in / Sign up

Export Citation Format

Share Document